Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Gabrielli

Showing results (131-140 of 288) with videos related to

Pageof 29
Sort By:
Giornale Italiano Di Cardiologia (2006)|June 25, 2026
[Ranolazine: established indications and emerging therapeutic potential]Stefania Angela Di Fusco, Luigi Pollarolo, Antonella Spinelli, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 8, 2020
Prevalence and Predictors of Out-of-Target LDL Cholesterol 1 to 3 Years After Myocardial Infarction. A Subanalysis From the EYESHOT Post-MI RegistryAngelo Silverio, Rossella Maria Benvenga, Federico Piscione, et al.
Frontiers in Cardiovascular Medicine|August 23, 2024
Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical settingGaetano Todde, Lorenzo Lupo Dei, Roberto Polizzi, et al.
JACC. Advances|August 12, 2024
Characteristics and Management of Patients With Cancer and Atrial Fibrillation: The BLITZ-AF Cancer RegistryMichele Massimo Gulizia, Fabio Maria Turazza, Pietro Ameri, et al.
International Journal of Molecular Sciences|October 26, 2024
Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer PatientsVincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[ANMCO Statement: semaglutide in cardio-nephro-metabolic disorders]Leonardo De Luca, Claudio Bilato, Alessandro Navazio, et al.
Giornale Italiano Di Cardiologia (2006)|May 27, 2026
[Gender bias and artificial intelligence in cardiology: evidence, clinical implications, and future perspectives]Maria Teresa Manes, Giuseppe Ciliberti, Antonia Mannarini, et al.
Giornale Italiano Di Cardiologia (2006)|April 27, 2023
[ANMCO Position paper: Wearable cardioverter defibrillator appropriate use guidance for the management of patients at high transient risk of sudden cardiac death]Giancarlo Casolo, Michele Massimo Gulizia, Daniela Aschieri, et al.
Frontiers in Cardiovascular Medicine|May 27, 2022
Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) SurveyMaria Laura Canale, Fabio Turazza, Chiara Lestuzzi, et al.
Giornale Italiano Di Cardiologia (2006)|April 19, 2024
[BLITZ-AF Cancer study: an international observational research project on patients with atrial fibrillation and cancer]Michele Massimo Gulizia, Fabio Maria Turazza, Pietro Ameri, et al.
Pageof 29

Showing results (131-140 of 288) with videos related to

Sort By:
Pageof 29
Giornale Italiano Di Cardiologia (2006)|June 25, 2026
[Ranolazine: established indications and emerging therapeutic potential]Stefania Angela Di Fusco, Luigi Pollarolo, Antonella Spinelli, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 8, 2020
Prevalence and Predictors of Out-of-Target LDL Cholesterol 1 to 3 Years After Myocardial Infarction. A Subanalysis From the EYESHOT Post-MI RegistryAngelo Silverio, Rossella Maria Benvenga, Federico Piscione, et al.
Frontiers in Cardiovascular Medicine|August 23, 2024
Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical settingGaetano Todde, Lorenzo Lupo Dei, Roberto Polizzi, et al.
JACC. Advances|August 12, 2024
Characteristics and Management of Patients With Cancer and Atrial Fibrillation: The BLITZ-AF Cancer RegistryMichele Massimo Gulizia, Fabio Maria Turazza, Pietro Ameri, et al.
International Journal of Molecular Sciences|October 26, 2024
Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer PatientsVincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[ANMCO Statement: semaglutide in cardio-nephro-metabolic disorders]Leonardo De Luca, Claudio Bilato, Alessandro Navazio, et al.
Giornale Italiano Di Cardiologia (2006)|May 27, 2026
[Gender bias and artificial intelligence in cardiology: evidence, clinical implications, and future perspectives]Maria Teresa Manes, Giuseppe Ciliberti, Antonia Mannarini, et al.
Giornale Italiano Di Cardiologia (2006)|April 27, 2023
[ANMCO Position paper: Wearable cardioverter defibrillator appropriate use guidance for the management of patients at high transient risk of sudden cardiac death]Giancarlo Casolo, Michele Massimo Gulizia, Daniela Aschieri, et al.
Frontiers in Cardiovascular Medicine|May 27, 2022
Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) SurveyMaria Laura Canale, Fabio Turazza, Chiara Lestuzzi, et al.
Giornale Italiano Di Cardiologia (2006)|April 19, 2024
[BLITZ-AF Cancer study: an international observational research project on patients with atrial fibrillation and cancer]Michele Massimo Gulizia, Fabio Maria Turazza, Pietro Ameri, et al.
Pageof 29